About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Responses to E-Cigarette Advertising | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDEARLY Phase 1NCT04249219

Responses to E-Cigarette Advertising

While conventional cigarette use continues to decline among youth and young adults, e-cigarette (EC) use is on the rise. The use of ECs during young adulthood, particularly 18 years of age, is especia...

Lead sponsor: University of Massachusetts, Worcester•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Massachusetts, Worcester

Collaborators

National Institute on Drug Abuse (NIDA)

Age

18 - 26 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•18-26 years old,
•Fluent in English,
•Biochemically confirmed abstinence combusted tobacco or marijuana (eCO: exhaled carbon monoxide \<6 parts per million) at time of visit
•Reporting never trying an e-cigarette, not even a puff OR reporting having used an e-cigarette in the past but has not used in the past 30 days
•Susceptibility to EC use, will be determined using the Susceptibility to Use Tobacco Products questionnaire

Exclusion Criteria

•Younger than 18 years or older than 26 years
•Not fluent in English
•Not confirmed abstinent of combusted tobacco or marijuana
•Use of an e-cigarette
•Not susceptible to e-cigarette use

Related studies

The Role of Flavor in the Substitutability of E-cigarettes for Combustible Cigarettes Among Persistent Smokers

NCT06264154 · Smoking, Tobacco Use, and more

Clinical Alternatives for Reducing Harm Using E-cigarettes

NCT07039292 · Smoking, E-Cig Use, and more

Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use E-cigarettes and Cannabis (Co-Tox Study)

NCT07167225 · Cigarette Smoking-Related Carcinoma, E-Cig Use

BREATHE Free: a Pilot Feasibility Trial

NCT06862050 · Smoking Cessation; Tobacco Dependence, E-Cig Use, and more

Sex Differences in E-cig Perception: Study 1

NCT05432830 · Nicotine Addiction, E-Cig Use, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 8, 2023Terms

Trial snapshot

StatusCOMPLETED

PhaseEARLY_PHASE1

Enrollment62

Start dateAug 2021

Last updatedSep 8, 2023

Condition

Locations shown

University of Massachusetts Medical School

Worcester, Massachusetts

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 8, 2023Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions